Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.
5 Factors Linked to Greater Chance of Polycythemia Vera Progression
Researchers identified five traits that may increase a person’s chance of experiencing polycythemia vera progression.
Read More
FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Listen
I Am a ‘Cancer Patient Person’ Navigating an Ever-Changing New Normal
I have an incurable cancer, which forces me — and my loved ones — to be ever-adapting in this physical and emotional battle.
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
Lower Childbirth Rates Shown in Women With MPNs
Childbirth rates have been reduced by 22% in women with MPNs, compared with women without MPNs, researchers found.
New Drug May Decrease Need for Blood Draws in Patients With PV
Treatment with rusfertide led to a decrease in the need for blood draws and decreased levels of red blood cells in patients with polycythemia vera.